Published in:
01-03-2020 | Thymoma | Original Article
Immunosuppressive therapy for elderly-acquired pure red cell aplasia: cyclosporine A may be more effective
Authors:
Xiaoqing Liu, Xingyu Lu, Lang Chen, Yan Yang, Xuemei Wu, Ruinan Lu, Shuai Wang, Jianfu Zhang, Ming Hong, Yu Zhu, Guangsheng He, Jianyong Li
Published in:
Annals of Hematology
|
Issue 3/2020
Login to get access
Abstract
This current study retrospectively analyzed the clinical characteristics of 69 adult patients with acquired pure red cell aplasia (PRCA) including 40 elderly and 29 non-elderly patients from September 2009 to June 2019. The remission induction therapy regimens included cyclosporine A (CsA), corticosteroids (CS), or other immunosuppressive agents. The overall response rate was 55% (22/40) in the elderly group compared with 75.9% (22/29) in non-elderly patients (P = 0.075). In elderly patients, the best remission was achieved in the group treated with CsA than those treated with CS or other immunosuppressive agents (83.3% vs 26.7% vs 42.9%%, P = 0.004). However, outcomes of remission were similar among different treatment groups (P = 0.458) in non-elderly patients. CS induced a higher response rate in the non-elderly than that in the elderly (88.9% vs 26.7%, P = 0.009). By univariate and multivariate analysis, the clinical efficacy of elderly patients with acquired PRCA was closely associated with an induction regimen of CsA (P = 0.009; P = 0.017). In conclusion, CsA might produce higher response rate than CS and other drugs in elderly patients with acquired PRCA.